Unusual Machinesの空売り状況は、投資家がUnusual Machinesの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Unusual Machines (AMEX:UMAC) 株価情報, 空売り情報

Unusual Machines

Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.

Unusual Machines Inc

According to a <a href="https://explodingtopics.com/blog/messaging-apps-stats#top-messaging-app-statistics-2025-editors-picks">recent report</a> on messaging apps, 2 billion users are engaging with these apps every month. 
Telegram has 900 million monthly users, making it the fourth most used messaging app, but Telegram has the most downloads with 48.4 million per month. Beyond competing with Twitter (X) as the prime source of news and information for the Web3 world, Telegram is a potential source of revenue, with over $8 million/month spent on in-app purchases. 
According to the report, 85% of Telegram users look for news channels. 
An <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41437710/v3v-ventures-invests-5-million-in-premium-telegram-usernames-seizing-unique-advantages-to-">earlier report</a> by CoinGecko showed that 73.8% of crypto users get their blockchain news primarily from social media, with Twitter (X) as the leader (41.7%) and Telegram in second place (21.5%). 
Just 5% get their news from crypto news websites. 
We spoke with <a href="https://www.instagram.com/aleksandr_savieliev">Oleksandr Savieliev</a>,  CEO and Founder of TripleA, a Telegram mini-app and cross-market news aggregator that combines feeds for 90+ sources and uses AI to deliver a targeted mix of crypto, stocks, VC, gaming and more.  
The app offers customizable news feeds, portfolio management tools, and an AI investment assistant for sectors such as crypto, stocks, VC, gambling, MLM and influence markets.
"TripleA is a fully personalized news and analytics platform. Our AI assistant doesn't just surface trending headlines – it learns your behavior across markets, curates relevant stories, removes duplication, and helps you draw cross-sector insights."
 TripleA targets cross-over audiences interested in both traditional finance and digital assets. 
"TripleA is built for a broad, multi-market audience. We're not limiting ourselves to just Web2 or Web3. Of course, Web3 natives like degens are welcome, especially since many already live on Telegram, but we're designing the platform to feel intuitive for both traditional users and decentralized communities. The value is in the curation and personalization," Savieliev said.
AI-driven news personalization could be a significant differentiation from basic RSS readers or Telegram channels because it offers the chance for insight curation, not just news aggregation, letting users control the signal-to-noise ratio.
"It&#8217;s like having a smart research analyst working alongside you. The multi-market integration – crypto, stocks, influencers, VCs, politics, etc. – with predictive analytics and sentiment scoring sets us apart."
The TripleA mini-app is pre-launch and plans to add a Risk Radar. That feature could be handy with news for crypto and other high-risk asset classes.
"We're planning an AI-based &#8220;risk radar&#8221; feature that highlights asset volatility, controversial influencers, or speculative trends – so users can make informed decisions, not emotional ones."
The mini-app has a broad scope. It uses AI to aggregate news from many sources and areas of interest in a customizable way. The app is also transactional.
"Our investment assistant is designed to simplify complex portfolio tracking. It pulls in your public wallet data and allows you to monitor your holdings – across multiple blockchains and markets – within a single dashboard. It doesn't require custody, so it's safe. Initially, we'll support basic tracking and TON-native transactions to comply with the ecosystem. Later, we'll integrate broader EVM-compatible wallets for in-app portfolio actions, but always in a non-custodial, privacy-first manner."
Before founding TripleA, Savieliev previously led Infine IT, an enterprise tech builder, and co-founded, then exited, a media channel called All-Seeing Eye. 
Savieliev emphasizes speed to market and execution and sees TripleA as a game-changer. 
"TripleA isn't just another app. It's a mission to redefine how people consume information in an era of overload. Whether you're checking the news, analyzing investments, or trying to keep up with a volatile market, we want to be the platform you trust. With our AI, cross-platform flexibility, and future-focused design, we're building more than a tool – we're building an ecosystem of insight."
It is notable that although TripleA appeals to a Web3 and mainstream audience, the project makes judicious compromises around decentralization. "TripleA is a hybrid by design. The front end and user experience are streamlined and centralized to deliver speed and usability. But we integrate decentralized technologies where they matter – like wallet tracking, data ownership, and smart contract-based rankings or incentives. Our goal isn't to decentralize everything – it's to make intelligence and personalization accessible while honoring Web3 values like privacy, control, and transparency."
Savieliev says his leadership is informed by a personal focus on meditation and consciousness-expanding practices, including ayahuasca ceremonies, which he credits with deepening his self-awareness.
TripleA is currently in its Minimum Viable Product (MVP) phase but claims it has seen pre-launch interest especially in Europe, Southeast Asia, and Latin America.  
To serve these markets, it plans to add a number of languages beyond English. 
The team is ready to scale for global adoption, and say it is on track to onboard its first 10,000 users in the next few months.
Image courtesy of Oleksandr Savieliev.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

Social Media

Exclusives

Interview

Oleksandr Savieliev Says Your Telegram Feed Is About To Get Smarter

Nebius Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIS#NASDAQ">NBIS</a>) shares have been trending in recent weeks as the stock has surged from the low $20 range to above $35. Here&#8217;s a look at <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45295132/nebius-stock-is-rallying-this-week-as-amazons-bezos-leads-funding-for-ai-data-unit">what&#8217;s going on</a>.
What To Know: Nebius shares have seen increased attention from retail traders in recent weeks, specifically on social media platform X where several investors are discussing growth potential and making the case for owning the stock long term.
The stock has risen approximately 67% over the past month and nearly 30% over the past week after the company announced a strategic investment from&nbsp;Bezos Expeditions, the investment arm of Amazon's&nbsp;Jeff Bezos. The investment also includes participation from a Shopify executive and is specifically focused on the company&#8217;s AI data solutions business Toloka. 
The company is also backed by Nvidia, which participated in a $700 million capital raise with a group of investors in December. Nebius shares reached an all-time high in mid-February after a regulatory <a href="https://www.sec.gov/Archives/edgar/data/1045810/000104581025000013/xslForm13F_X02/information_table.xml">filing</a> from Nvidia showed that the company was holding approximately 1.19 million shares of the AI infrastructure company. 
With the 13-F filing deadline set for May 15, it&#8217;s likely that Nvidia will soon report updated holdings for the first quarter. Investors will be watching closely to see if Nvidia still holds a stake in Nebius. 
Nebius shares retreated from highs after the company reported fourth-quarter financial results in February. Total revenue increased 466% year-over-year, driven by the company&#8217;s core AI infrastructure business, which grew 602% year-over-year. It was also hurt by a broader market sell-off in anticipation of tariffs from the Trump Administration.
&#8220;The fourth quarter was extremely eventful for Nebius. Our shares resumed trading on Nasdaq in October, and we went on to raise $700 million in December in an over-subscribed capital raise from top-tier partners including Nvidia, Accel and Orbis,&#8221; the company said in its fourth-quarter earnings release.
"In Q4 we also focused on building out our sales function, and we are now seeing the results. More clients are coming onto the platform, and our more diversified customer base is already contributing to strong growth in annualized run-rate revenue (ARR). Based on contracts already in place, March ARR will be at least $220 million, and we have additional potential deals in the pipeline.&#8221;
Nebius competitor CoreWeave, which is also backed by Nvidia, reported its first <a href="https://www.benzinga.com/news/earnings/25/05/45421041/nvidia-backed-coreweave-reports-q1-earnings-revenue-jumps-420-backlog-grows-to-25-9-billion-following-openai-deal-shares-hit-all-time-highs">quarterly results</a> as a public company on Wednesday and announced <a href="https://www.benzinga.com/25/05/45445485/coreweave-stock-surges-to-highs-of-the-session-after-company-reveals-details-of-openai-deal">new details</a> of its deal with OpenAI on Thursday, which appears to be adding to the excitement surrounding the sector. 
Nebius has a Street-low price target of $30 and a Street-high target of $60 from analysts, according to <a href="https://www.benzinga.com/quote/NBIS/analyst-ratings">Benzinga data</a>. Most recently, Northland Capital Markets initiated coverage on the stock with an <a href="https://www.benzinga.com/analyst-stock-ratings">Outperform rating</a> and a target of $34. The coverage came a day ahead of the investment announcement from Bezos Expeditions. 
NBIS Price Action: <a href="http://benzinga.com/quote/nbis">Nebius Group shares</a> were down 0.29% at $36.02 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45441683/these-analysts-boost-their-forecasts-on-coreweave-after-q1-results">These Analysts Boost Their Forecasts On CoreWeave After Q1 Results</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/gorodenkoff">Gorodenkoff</a>/Shutterstock.

News

Movers

NBIS

Investors Are Watching Nebius Group Stock: Here's Why

AppTech Payments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APCX#NASDAQ">APCX</a>) reported quarterly losses of $(0.08) per share. This is a 38.46 percent increase over losses of $(0.13) per share from the same period last year. The company reported $217.00 thousand in sales this quarter. This is a 106.67 percent increase over sales of $105.00 thousand the same period last year.

Earnings

APCX

AppTech Payments Q1 EPS $(0.08) Up From $(0.13) YoY, Sales $217.00K Up From $105.00K YoY

<a href="https://subscriber.politicopro.com/article/2025/05/va-secretary-wants-to-find-answers-on-psychedelic-therapies-for-veterans-00352039" title="https://subscriber.politicopro.com/article/2025/05/va-secretary-wants-to-find-answers-on-psychedelic-therapies-for-veterans-00352039">https://subscriber.politicopro.com/article/2025/05/va-secretary-wants-to-find-answers-on-psychedelic-therapies-for-veterans-00352039</a>

CMPS

CYBN

DRUG

ENVB

MNMD

SEEL

"VA Secretary Wants To Find Answers On Psychedelics Therapies For Veterans; Doug Collins Pointed Out That There Are 11 Trials Underway At The VA Into Use Of Psychedelics Like Psilocybin And MDMA" - Politico

Veteran hedge fund manager Doug Kass isn't mincing words about the state of the cannabis industry. In a recent column titled &#8220;<a href="https://pro.thestreet.com/market-commentary/kass-picking-the-cannabis-winners-in-an-industry-full-of-the-walking-dead">Picking the Cannabis Winners in an Industry Full of the Walking Dead</a>,&#8221; the Seabreeze Partners president outlined why he believes most public cannabis companies are distressed and structurally unsound — but also identified a small group he still considers investable.
<h3 class="wp-block-heading">&#8216;The Walking Dead&#8217; Of Weed Stocks</h3>
According to Kass, a majority of cannabis equities today are effectively "walking dead," their survival contingent on the ability to refinance mounting debt. And even for those that manage to raise capital, significant equity dilution could leave shareholders with little value.
"The cannabis industry now consists of only a handful or two of private and public companies that are healthy and who reside in the land of the living," Kass wrote. "Most of the other public equities are among the walking dead."
He argues the industry's earlier projections for market size, sales and profitability were dramatically overstated, leading to disappointing results and poor investor returns. That disillusionment has been compounded by structural headwinds — oversupply, inconsistent state-level rollouts and sluggish legalization progress — all contributing to weak dispensary unit economics and price compression.
Kass also noted that access to capital has dried up, leading some operators to delay tax payments or take on unmanageable debt.
<h3 class="wp-block-heading">MSOS ETF In The Crosshairs</h3>
Kass reserved particularly harsh criticism for the AdvisorShares Pure U.S. Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>), which he says has become "the tail that wags the cannabis dog."
After years of holding a position in the ETF, Kass said he sold out a couple of weeks ago, citing concerns over its portfolio construction, illiquid holdings, and role in sector volatility.
"Frankly, given that the components of MSOS are illiquid, I do think (though it is hard to prove) that the industry would have been better off if MSOS never existed," he wrote. "MSOS has clearly become the tail that wags the cannabis dog."
He accused the ETF's managers of disposing of stronger companies like Green Thumb Industries in order to fund weaker names, which he believes may have provided exits for insiders at the expense of retail shareholders.
<h3 class="wp-block-heading">Four Marijuana Stocks Worth Watching</h3>
Despite his bearish view of the broader market, Kass said a select few companies remain attractive, particularly for long-term investors with patience. His shortlist includes:
<ul class="wp-block-list">
<li>Trulieve Cannabis Corp. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>)</li>
<li>TerrAscend Corp. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TRSSF#OTCQX">TRSSF</a>)</li>
<li>Green Thumb Industries Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>)</li>
<li>Glass House Brands Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GLASF#OTCQX">GLASF</a>)</li>
</ul>
Kass argues that each of these operators is financially and operationally stronger than its peers and could benefit from potential industry consolidation and legislative progress in the coming years.
"While there are other stocks that are investable, their market capitalizations are too small and their liquidity limited," he wrote. "Even the best of the cannabis lot will require patience — but there remains consequential upside (and relatively limited downside) over the next several years."
It should be noted, though, that Kass published his commentary on May 5. Since then, all four companies have reported first-quarter results:
<ul class="wp-block-list">
<li>Trulieve posted $298 million in revenue, 62% gross margin and $51 million in cash flow from operations.</li>
<li>TerrAscend reported $71 million in revenue and its 11th consecutive quarter of positive operating cash flow.</li>
<li>Green Thumb delivered $280 million in revenue, $74 million in operating cash flow and $8 million in net income.</li>
<li>Glass House&#8217;s revenue increased 49% year over year to $44.8 million and achieved a 45% gross margin despite declining production costs.</li>
</ul>
<h3 class="wp-block-heading">Looking Ahead: Consolidation, Legislation And Distribution Models</h3>
Kass believes the next 12 to 18 months could bring widespread receiverships among debt-laden cannabis companies. This "debt maturity cliff," combined with potential M&amp;A activity, may create openings for stronger players to grow through acquisition.
He also raised questions about the future of cannabis distribution:
<ul class="wp-block-list">
<li>If interstate commerce becomes legal, low-cost national cultivators like Glass House may win out.</li>
<li>If distribution remains intrastate, vertically integrated MSOs with strong local operations could continue dominating — assuming they can survive market dynamics.</li>
</ul>
<h3 class="wp-block-heading">Bottom Line</h3>
Kass's analysis is a reminder for cannabis investors that selectivity is critical. While the broader sector faces significant headwinds, a few well-capitalized, strategically positioned companies may still present compelling long-term opportunities.
Photo: Shutterstock

Cannabis

Long Ideas

Short Ideas

Hedge Funds

Trading Ideas

GLASF

GTBIF

MSOS

TCNNF

TRSSF

Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are 'Walking Dead,' But These 4 Names Stand Out

In a move that indicates faith in the resurgence of global equities, Lazard Asset Management has transformed its International Equity Advantage mutual fund into<a href="https://www.benzinga.com/etfs"> actively managed ETF</a>, the Lazard International Dynamic Equity Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEQ#NYSE">IEQ</a>). With this, IEQ joins Lazard&#8217;s theme- and region-based ETF suite that includes the Equity Megatrends ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THMZ#NASDAQ">THMZ</a>), Japanese Equity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JPY#NASDAQ">JPY</a>), and Next Gen Technologies ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEKY#NASDAQ">TEKY</a>).
Also Read:<a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45297474/imtm-etf-tanks-then-soars-why-global-momentum-is-making-a-comeback"> IMTM ETF Tanks, Then Soars: Why Global Momentum Is Making A Comeback</a>
Launched on Monday, IEQ is not starting from zero. It inherits both the history and portfolio DNA of its mutual fund ancestor, now in the slick, low-cost, and tax-efficient wrapper increasingly favored by investors. The ETF launched with $31.1 million in assets and an expense ratio of 0.40%.
IEQ follows the MSCI All Country World ex-US Index (ACWI ex-US) as its benchmark but seeks to outperform it, not merely replicate it. The fund uses a quantitatively oriented process that combines machine intelligence with fundamental research to create a concentrated, high-conviction portfolio of non-U.S. stocks.
The fund&#8217;s strategy resists temptation to lean too heavily in any one direction of investment. Rather, Lazard&#8217;s team regularly assesses companies on the basis of valuation, growth, quality, and the way markets are thinking about them.
Rob Forsyth, Lazard's Global Head of ETFs, sees the &#8220;pendulum swing back toward international equities,&#8221; and investors are taking notice.
Additionally, Lazard Chief Market Strategist Ronald Temple sees a &#8220;world of opportunity&#8221; outside of the U.S., according to Bloomberg.
IEQ's portfolio includes global powerhouses such as TSMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), Iberdrola (OTCPK: IBDRY), Novartis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>), Alibaba (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), and Tencent (OTCPK: TCEHY), offering exposure across key regions and sectors.
As the ETF market starts to sizzle and international shares return to favour with investors, Lazard is betting that an experienced international strategy with a technology-driven twist is precisely what the market needed. IEQ might be a new ticker tape name, but the strategy playbook that underlies it has been rigorously stress-tested through market cycles — and now it&#8217;s taking it global.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/05/45446558/new-innovator-etf-targets-rolling-downside-protection-with-up-to-50-equity-upside">New Innovator ETF Targets Rolling Downside Protection With Up To 50% Equity Upside</a></li>
</ul>
Image: Shutterstock

New ETFs

ETFs

BABA

IBDRY

TCEHY

TEKY

THMZ

Lazard Transforms Mutual Fund Into IEQ ETF Amid Rising Demand For International Stocks

T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>)&nbsp;and cybersecurity provider Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45435467/t-mobile-and-palo-alto-networks-to-launch-managed-sase-offering-for-wireless-devices" rel="noreferrer noopener">on Thursday introduced</a> &#8216;T-Mobile SASE, with Palo Alto Networks,&#8217; a new managed offering that combines a&nbsp;5G advanced network, T-Mobile&#8217;s T-SIMsecure with T-Mobile Security Slice, and Palo Alto Networks&#8217; Prisma SASE 5G.
The offering will deliver enhanced protection, performance, and simplicity to T-Mobile for Business customers.
Palo Alto Networks Prisma SASE 5G, the cloud-native Zero Trust security solution, expands T-Mobile&#8217;s security portfolio, enabling organizations to better protect their networks and devices without needing extra equipment or software.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/45018003/t-mobile-slides-after-q1-but-analyst-still-bullish-on-broadband-growth-and-wireless-strength" rel="noreferrer noopener">T-Mobile Beats Estimates, But Customer Growth Leaves Investors Wanting More, Says Analyst</a>
It empowers businesses and government agencies to connect users and devices to private more securely, Software as a Service (SaaS), and internet applications while maintaining strict security policies and visibility.
Integrating Alto Networks&#8217; SASE capabilities into T-Mobile&#8217;s network protects customer data more effectively across endpoints.
The number of business 5G IoT connections in North America is expected to grow from five million in 2025 to 39 million by 2030.
Palo Alto Networks surged 23% in the last 12 months. The company snapped up an AI security startup called Protect AI at a <a href="https://www.benzinga.com/personal-finance/25/05/45184304/palo-alto-networks-acquires-protect-ai-for-500m-a-startup-backed-by-salesforce-samsung-and-01-advisors-in-ai-security-push" target="_blank" rel="noreferrer noopener">valuation of over</a> $500 million. The deal is expected to close later this year.
Wedbush analyst Dan Ives <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44670176/nvidia-apple-top-names-to-own-cybersecurity-stocks-to-outperform-tech-analyst-dan-ives-says" target="_blank" rel="noreferrer noopener">named it among</a> his defensive picks, suggesting investors could rotate from semis to software to hunker down amid the current market volatility.
T-Mobile US stock surged 48% in the last 12 months. Scotiabank analyst Maher Yaghi upgraded the rating, citing <a href="https://www.benzinga.com/25/04/45119505/t-mobiles-consistent-subscriber-growth-and-strong-market-trends-prompt-analyst-upgrade" target="_blank" rel="noreferrer noopener">healthy subscriber growth</a> and strong industry trends despite a recent stock drop.
Price Actions: T-Mobile US stock is up 2.63% to $241.49 at last check on Thursday. PANW is up 1.45%.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45298528/comcast-gains-analyst-praise-for-parks-expansion-and-strong-wireless-despite-broadband-hurdles" target="_blank" rel="noreferrer noopener">Comcast Growth Steps Will Take &#8216;A Minimum Of Several Quarters&#8217; To Generate Returns: Analyst</a></li>
</ul>
Image via Shutterstock

Tech

PANW

TMUS

T-Mobile, Palo Alto Partner To Enhance 5G Cybersecurity For US Businesses

WIIM

ILMN

Illumina shares are trading higher after members of management disclosed stock purchases.

Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has announced a major leadership transition, appointing Dave Rosa as the company&#8217;s next <a href="https://www.benzinga.com/pressreleases/25/05/g45436448/intuitive-announces-ceo-transition-effective-july-1-2025">chief executive officer, effective July 1, 2025</a>.
Rosa, who currently serves as president, will succeed long-serving CEO Gary Guthart, who will become the executive chair of the board.
The move is part of a broader succession strategy as the robotic-assisted surgery pioneer celebrates its 30th anniversary.
As part of the transition, Craig Barratt, the current board chair, will take on the role of lead independent director.
Also Read: <a href="https://www.benzinga.com/general/biotech/25/05/45438765/why-pfizer-is-poised-for-a-strong-comeback-my-top-pick-for-2025" target="_blank" rel="noreferrer noopener">Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025</a>
Guthart, who has led the company for 15 years, will stay on in a senior advisory capacity to support a seamless transition.
Rosa, who joined Intuitive nearly 30 years ago as its ninth employee, has served in multiple roles across engineering, product development, marketing, and commercial operations.
The company recently revealed that the FDA has recently cleared Intuitive&#8217;s da Vinci SP system for transanal local excision/resection, a minimally invasive surgery <a href="https://www.benzinga.com/pressreleases/25/05/g45135080/intuitive-announces-fda-clearance-of-da-vinci-single-port-for-transanal-local-excisionresection" target="_blank" rel="noreferrer noopener">done without abdominal cuts</a>.
This expands the system&#8217;s use in colorectal procedures through natural orifices. It builds on earlier FDA approvals from November 2024 for several transabdominal colorectal surgeries.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, ISRG stock has gained over 39% in the past year.
Investors can gain exposure to the stock via&nbsp;Spinnaker ETF Series Langar Global HealthTech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGHT#NYSE">LGHT</a>) and&nbsp;iShares U.S. Medical Devices ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHI#NYSE">IHI</a>).
Price Action: ISRG shares are trading lower by 1.69% to $556.38 at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45439079/powell-signals-fed-may-shift-its-inflation-strategy-after-5-year-economic-shake-up" target="_blank" rel="noreferrer noopener">Powell Signals Fed May Shift Inflation Strategy After 5 Years Of Economic Upheaval</a></li>
</ul>
Image via Shutterstock

Equities

Health Care

Management

Markets

General

iShares Dow Jones US Medical Devices Index Fund

ISRG

LGHT

What's Going On With Intuitive Surgical Stock On Thursday?

EXEL

Exelixis shares are trading higher after the company recently reported better-than-expected Q1 financial results and raised its FY25 sales guidance with its midpoint above estimates. The company, acting as a collaboration partner of Invenra, initiated the dose-escalation stage of the first-in-human Phase 1 clinical study of XB628. On Thursday, Citigroup raised its price target from $45 to $56.

AquaBounty Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQB#NASDAQ">AQB</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $(0.61) by 126.23 percent. This is a 122.86 percent increase over losses of $(0.70) per share from the same period last year.

Earnings Beats

CORRECTION: AquaBounty Techs Q1 EPS $0.16 Beats $(0.61) Estimate

In A Letter To Shareholders, DDC Enterprise CEO Norma Chu Announces DDC's Bitcoin Accumulation Strategy; Commits Immediate Execution Of A 100 BTC Acquisition, With A Target To Accumulate 500 BTC Within Six Months And 5,000 BTC Within 36 Months

<ul>
<li>Zynyz&#xAE; (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with chemotherapy and as a monotherapy</li>
<li>Patients with SCAC treated with Zynyz achieved a statistically significant improvement in progression-free survival and improvement in overall survival</li>
</ul>
Incyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz&#xAE; (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy.

INCY

Incyte Announces FDA Approval Of Zynyz Making It First And Only Approved First-Line Treatment For Advanced Anal Cancer Patients In US

STERIS shares are trading higher after the company reported better-than-expected Q4 financial results and issued guidance above estimates.

Shares of Cisco Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) were climbing in early trading on Thursday, after the company Wednesday reported its <a href="https://www.benzinga.com/news/earnings/25/05/45422303/cisco-shares-climb-after-q3-eps-revenue-beat-estimates-details">fiscal third-quarter results</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
Rosenblatt Securities On Cisco Systems
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/628b6bab3547bd000104dc00/mike-genovese">Analyst Mike Genovese</a> reaffirmed a Buy rating, while raising the price target from $63 to $74.
Cisco Systems reported revenues and earnings of $14.15 billion and 96 cents per share, ahead of estimates, with the outperformance being driven by networking, Genovese said in the note. Gross margins were also better than expected, with a lower-than-expected tariff impact, higher productivity and Splunk margin expansion, he added.
The midpoint of the fourth-quarter revenue guidance came in at $14.60 billion, around $200 million higher than expected, the analyst stated. Cisco Systems is outperforming peer Arista Networks Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) in the AI cycle, as "it has become more responsive to Hyper Scale customer needs," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Goldman Sachs On Cisco Systems
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5a1c4e20efacff00015a984c/michael-ng">Analyst Michael Ng</a> maintained a Neutral rating and price target of $63.
Networking and Collaboration revenue came in higher than expected, more than offsetting the miss in Security, Ng said. Cisco Systems recorded webscale AI orders of more than $600 million, accelerating from $350 million in the previous quarter, he added.
Enterprise orders grew by 22%, driven by Splunk, the analyst stated. "Tariff headwinds were more moderate than expected given the pause in reciprocal tariffs and semiconductor &amp; select product exemptions," he further wrote.
CSCO Price Action: Shares of Cisco Systems had risen by 5.74% to $64.81 at the time of publication on Thursday.
Read More: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst">&nbsp;Cisco Is Targeting A Multi-Billion-Dollar Security Shake-Up—And It Starts With Killing The Firewall</a>
Photo: Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

ANET

CSCO

Cisco Systems Posts Q3 Beat; Is Outperforming Arista Networks In The AI Cycle, Analysts Say

Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)&nbsp;<a href="https://www.benzinga.com/pressreleases/25/05/g45436027/broadcom-announces-third-generation-co-packaged-optics-cpo-technology-with-200glane-capability" target="_blank" rel="noreferrer noopener">announced significant advancements</a> in its co-packaged optics (CPO) technology on Thursday, with the launch of its third-generation 200G per lane (200G/lane) CPO product line.
Broadcom highlighted key improvements in OSAT processes, thermal designs, handling procedures, fiber routing, and overall yield.
Broadcom&#8217;s leadership in CPO began in 2021 with its first-generation Tomahawk 4-Humboldt chipset, enabling an early learning cycle across the entire CPO supply chain.
Also Read: <a href="https://www.benzinga.com/25/05/45417156/nvidia-amd-stocks-climb-as-trump-plans-to-ease-ai-chip-export-rules" target="_blank" rel="noreferrer noopener">Nvidia, AMD And Other Chip Stocks Gain As Trump Plans To Ease AI Chip Export Rules</a>
This chipset introduced key innovations, including high-density integrated optical engines, edge coupling, and detachable fiber connectors.
Building on that success, the second-generation Tomahawk 5-Bailly (TH5-Bailly) chipset became the industry&#8217;s first volume-production CPO solution.
As part of the TH5-Bailly production, Broadcom focused on automated testing and scalable manufacturing processes, setting the stage for high-volume production of future generations.
Broadcom&#8217;s partners included Corning Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>), Delta Electronics, and Foxconn Interconnect Technology.
On Tuesday, Corning <a target="_blank" href="https://www.benzinga.com/tech/25/05/45379380/can-corning-broadcom-deal-transform-ais-data-center-future" rel="noreferrer noopener">announced a partnership</a> with Broadcom to power AI data centers with advanced optics for faster, more efficient processing.
Corning will supply advanced optical components for Broadcom&#8217;s Bailly CPO system, making it ideal for large-scale artificial intelligence (AI) clusters.
<h2 class="wp-block-heading">Broadcom Stock Prediction For 2025</h2>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of Broadcom have an average 1-year price target of $250.92, representing an expected upside of 7.41%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on Broadcom, while 13 analysts have bullish ratings. The street high price target from Cantor Fitzgerald is $300.0, while the street low from Citigroup is $210.0.
Price Action: AVGO stock is trading higher 0.19% to $232.55 at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/buybacks/25/05/45410939/amd-stock-pops-on-6-billion-buyback-plan-us-tariff-ease" target="_blank" rel="noreferrer noopener">AMD Stock Pops On $6 Billion Buyback Plan, US Tariff Ease</a></li>
</ul>
Image by Ken Wolter via Shutterstock

AVGO

Broadcom Unveils Next-Gen Optical Chip Tech To Power AI Data Centers

The FTX Recovery Trust will distribute more than $5 billion to creditors starting May 30, as part of its second payout under the <a href="https://www.benzinga.com/markets/cryptocurrency/22/11/29681030/ftx-files-for-chapter-11-bankruptcy">Chapter 11 bankruptcy plan</a>.
This marks a significant step in addressing claims from the collapse of FTX, the cryptocurrency exchange that <a href="https://www.benzinga.com/markets/cryptocurrency/22/12/30093147/you-think-ftx-was-bad-investors-suffered-far-greater-losses-from-terra-report">imploded in November 2022.</a>
The FTX collapse, one of the largest failures in crypto history, stemmed from allegations of mismanagement and fraud under former CEO Sam Bankman-Fried. 
The exchange, once valued at $32 billion, filed for bankruptcy after a liquidity crisis exposed a shortfall in customer funds. 
Bankman-Fried was later convicted of fraud, misappropriating $10 billion in customer assets, leading to a 25-year prison sentence. 
The fallout left thousands of customers and creditors awaiting repayment, with the Recovery Trust tasked with recovering and distributing assets.
The second distribution <a href="https://www.prnewswire.com/news-releases/ftx-recovery-trust-to-distribute-more-than-5-billion-to-creditors-in-second-distribution-on-may-30-2025-302456976.html">targets</a> holders of allowed claims in various classes who have met pre-distribution requirements. 
Funds will be disbursed through Bitgo or Kraken, with payments expected within one to three business days from May 30. 
John J. Ray III, the plan administrator, described the distribution as a milestone, noting the complexity of managing claims for a vast creditor base. He emphasized ongoing efforts to recover additional assets and resolve remaining claims.
Eligible creditors must complete Know Your Customer verification, submit tax forms, and onboard with a distribution service provider via the FTX Customer Portal. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45444794/bitcoin-is-starting-to-outperform-gold-jpmorgan">Bitcoin Is Starting To Outperform Gold: JPMorgan</a>
Those with transferred claims must ensure their details are updated with the claims agent. FTX warned of phishing scams, advising customers to verify communications and avoid connecting wallets to suspicious sites.
The distribution prioritizes different claim classes, with convenience claims receiving 120%, while customer and unsecured claims range from 54% to 72%. 
Future distribution dates will be announced, with similar requirements for eligibility. Separately, FTX Digital Markets Ltd. will handle claims for its customers.
FTX's downfall began when a November 2022 report revealed that Alameda Research, a hedge fund linked to Bankman-Fried, held significant illiquid assets tied to FTX's native token, FTT. 
A subsequent run on customer withdrawals exposed FTX's inability to cover deposits, triggering bankruptcy. 
Investigations uncovered that customer funds were misused to cover Alameda's losses, leading to <a href="https://www.benzinga.com/markets/cryptocurrency/22/11/29691585/why-ftxs-collapse-is-the-crypto-equivalent-of-the-2008-lehman-brothers-crisis">widespread financial harm</a>.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45441997/coinbase-hit-by-data-breach-refuses-to-pay-20m-ransom">Coinbase Hit By Data Breach, Refuses To Pay $20M Ransom</a></li>
</ul>
Image: Shutterstock

FTX To Distribute Over $5B To Creditors In Second Round Of Payouts On May 30

Needham analyst Mike Cikos reiterated the Buy rating on CoreWeave, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) on Thursday, <a target="_blank" href="https://www.benzinga.com/quote/CRWV/analyst-ratings" rel="noreferrer noopener">with a price forecast of $55.</a>
The company reported its first quarterly results as a public<a target="_blank" href="https://www.benzinga.com/25/05/45436747/coreweave-stock-is-volatile-thursday-whats-going-on" rel="noreferrer noopener"> company late Wednesday.&nbsp;</a>
CoreWeave said first-quarter revenue increased 420% year-over-year to $981.63 million, beating analyst&nbsp;<a target="_blank" href="http://benzinga.com/quote/crwv/earnings" rel="noreferrer noopener">estimates</a>&nbsp;of $859.77 million. The&nbsp;Nvidia-backed AI infrastructure company reported an adjusted loss of approximately 60 cents per share.
Cikos noted that CoreWeave's earnings highlighted a significant market opportunity and solid execution. Revenue surpassed expectations by 15%, and second-quarter guidance came in 9% above consensus at the midpoint.
Also Read: <a target="_blank" href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020" rel="noreferrer noopener">Tariffs Slow Retail Spending As Producer Prices Post Sharpest Drop Since 2020</a>
Cikos added that full-year revenue guidance was raised by 7%—fully incorporating the first-quarter beat, the second-quarter raise, and an implied increase for the second half of the year.
The analyst observed growing enterprise AI adoption, reflected in rising inference demand, which has encouraged management to accelerate investment, as data center capacity expanded from 1.3GW to 1.6GW.
While Cikos sees some stock volatility as investors digest the debt implications tied to funding CapEx, the analyst highlighted that CoreWeave has excelled in securing GPUs and assembling data center infrastructure in a highly constrained power environment, enabling it to gain market share amid soaring demand for AI compute.
He emphasized the company's bold and effective strategy for securing data center power—now at 360 active megawatts with over 1.3GW under contract—driven by flexible partnerships and innovative financing, including upfront CapEx to accelerate deployment timelines.
Cikos writes that the market may be underestimating the longevity of CoreWeave's infrastructure returns, noting that while GPUs are depreciated over six years, management sees a cash payback period of roughly 2.5 years and average contract durations of around four years.
The analyst added that the company could potentially realize value from its infrastructure well beyond the initial contract terms.
Price Action: CRWV shares are trading higher by 5.08% to $70.89 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45430835/us-stocks-likely-to-open-lower-after-sp-500s-three-day-winning-streak-many-uncertainties-remain-says-expert" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Lower After S&amp;P 500's Three-Day Winning Streak: ‘…Many Uncertainties Remain,' Says Expert</a></li>
</ul>
Image: Shutterstock

CRWV

CoreWeave Gears Up For AI Growth, But Debt Concerns May Jolt Stock, Says Analyst

SDOT

SDOT stock has given up its prior gain. Sadot Group shares were trading higher following Q1 reported financial results.

TSHA

Taysha Gene Therapies shares are trading higher following Q1 earnings.

Press Releases

Surge In Global Defense Budgets Having Significant Impact On The Global Military (UAS) Drone Market

Global Agriculture Drones Market Projected to Reach $8.03 Billion By 2029 with Significant Growth Still Expected

Offerings

Unusual Machines, Inc. Announces Proposed Public Offering

Unusual Machines, Inc. Announces Pricing of $40.0 Million Confidentially Marketed Public Offering of Common Stock

Unusual Machines To Report Financial Results for the First Quarter of 2025 and Provide Corporate Update

Unusual Machines, Inc. Announces Closing in which it Sold $40 Million in a Public Offering of Common Stock

Advancements In Drone Technology Opening Up New Applications as Market Size Estimated to Reach $57 Billion by 2028

Unusual Machines Issues Letter to Shareholders

Events

Unusual Machines to Exhibit at AUVSI XPONENTIAL 2025 in Houston, Showcasing U.S.-Made FPV Motors and Blue UAS Framework-Approved Components

Drone as a Service Market Well Poised for Sustained Growth in Commercial, Industrial and Civic Usage

ACHR

AGRI

BMV:ZENA

CSE:DPRO

DPRO

EVTL

KTOS

NVDA

PRZO

SIDU

SPAI

UMAC

ZENA

Coda Octopus Group

Electro-Sensors

Evolv Technologies Holdings, Inc. - Class A Common Stock

Evolv Technologies

Focus Universal

Frequency Electronics, Inc. - Common Stock

Frequency Electronics

Identiv

nLight

Interlink Electronics, Inc. - Common Stock

Interlink Electronics

LightPath Technologies, Inc. - Class A Common Stock

LightPath Technologies

908 Devices

MultiSensor AI Holdings, Inc. - Common Stock

MultiSensor AI Holdings

Maris Tech

Microvision

NOVONIX Limited - American Depository Shares

NOVONIX

Ouster

Red Cat Holdings

Research Frontiers Incorporated - Common Stock

Research Frontiers

SmartRent

Sono-Tek

ScanTech AI Systems

TROOPS

Vishay Precision Group, Inc. Common Stock

Vishay Precision Group

Vuzix

Wrap Technologies

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares

Zepp Health

Litchfield Hills

Maxim Group

ThinkEquity

Comments

Unusual Machines

空売り

Unusual Machines (AMEX:UMAC) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル